Original Article

Patients with Benign Hematological Disease


  • Sadullah GİRGİN
  • Ercan GEDİK
  • Bilsel BAÇ
  • İbrahim Halil TAÇYILDIZ

Received Date: 12.10.2008 Accepted Date: 15.10.2008 Eurasian J Emerg Med 2009;8(2):34-37


Surgical diseases of the spleen are most hematological diseases especially in patients with a severe refractory medical treatment. In this study, we assessed our clinical experience patients with benign hematological disease clinical outcome of the disease processes requiring splenectomy.


A retrospective review of the 115 patients who had undergone splenectomy for hematological diseases was reviewed. Age, gender, type of hematological disease, presence of accessory spleens and location, duration operation, Number of unit blood transfusion, length of hospital stay, long-term outcomes, morbidity and mortality were evaluated.


The mean age was 41.08±17.90 and, there were 67.8% female patients and 32.2% male patients. The most benign hematological disease which requiring splenectomy was idiopathic thrombocytopenic purpura (56.6%). The accessory spleens were encountered 26% patients during operation, and in six patients, who operated for anemia, were underwent cholesystectomy. Complication was occurred 9.56% and the most complication was atelectasia. A patient was died from postsplenectomic sepsis.


Investigation of accessory spleens would not be missed to prevent the recurrences and in these patients anticoagulant prophylaxis never be forgotten besides vaccination, and antibiotic prophylaxis.

Keywords: Hematological Disease, Splenectomy, Morbidity, Mortality